- This event has passed.
Next-Level Metrics: Defining a New Value Proposition
May 6, 2022 @ 12:30 pm - 1:30 pm EDT
Next-Level Metrics: Defining a New Value Proposition
Interested in putting more “oomph” in your value proposition within your company? Have your learning metrics plateaued and are you looking to take your metrics to the next level?
Join us for this LTEN webinar as we demonstrate how a clinical learning group at Abbvie is defining a whole new value proposition for their stakeholders. You’ll hear from Cheryle Gara, director of process & performance learning in Research & Development at Abbvie, and John Constantine, senior vice president at Orchestrall, as they show you how:
- To define the benefits delivery approach in your learning activities.
- You can weave benefits delivery in with your traditional learning metrics.
- Abbvie is doing this successfully.
Register today for this free, LTEN webinar. (Not an LTEN member? Join today and realize the value.)
RegisterPresenters
Cheryle Gara, MA, Director, Process & Performance Learning
AbbVie
Cheryle Gara joined AbbVie in 2001 and is currently the director of process & performance learning in the research & development area. She has held many positions related to the training field and is known for being a strategic leader with an energetic disposition who drives creative strategies that continuously promote change in performance and behavior.
In her current role, she has established her team as data-driven learning experts who lead innovative and high-quality learning experiences. As such, her dynamic learning organization not only deploys learning experiences, but leverages data to demonstrate impact and value.
John Constantine, SVP, Learning & Talent Solutions
Orchestrall
John is a veteran in the life sciences industry and former LTEN Board of Directors president. His expertise lying in the application of learning to business strategy to drive workforce effectiveness and the application of technology to learning to drive learning effectiveness and efficiency.